Mohsen Rashidi
- Molecular Biology top 10%
- Cancer Research top 5%
- Oncology top 10%
- Biomaterials top 10%
- Biomedical Engineering
- Co-authors
- Mehrdad HashemiAfshin TaheriazamMaliheh EntezariShokooh SalimimoghadamKiavash HushmandiMarjan GhorbaniSepideh MirzaeiMatin Chehelgerdi
- Topics
- MicroRNA in disease regulation (22 papers)Cancer-related molecular mechanisms research (22 papers)Circular RNAs in diseases (18 papers)
- Journals
- SHILAP Revista de lepidopterologíaCellular and Molecular Life SciencesFrontiers in Immunology
In The Last Decade
Mohsen Rashidi
91 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Molecular Biology 996
- Cancer Research 488
- Oncology 320
- Biomaterials 174
- Biomedical Engineering 166
Countries citing papers authored by Mohsen Rashidi
This map shows the geographic impact of Mohsen Rashidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohsen Rashidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohsen Rashidi more than expected).
Fields of papers citing papers by Mohsen Rashidi
This network shows the impact of papers produced by Mohsen Rashidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohsen Rashidi. The network helps show where Mohsen Rashidi may publish in the future.
Co-authorship network of co-authors of Mohsen Rashidi
This figure shows the co-authorship network connecting the top 25 collaborators of Mohsen Rashidi. A scholar is included among the top collaborators of Mohsen Rashidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohsen Rashidi. Mohsen Rashidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapybreakdown → | 113 |
| 2 | 3 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 8 | |
| 6 | 1 | |
| 7 | 13 | |
| 8 | 0 | |
| 9 | 3 | |
| 10 | 4 | |
| 11 | 3 | |
| 12 | 15 | |
| 13 | 35 | |
| 14 | 0 | |
| 15 | 40 | |
| 16 | 15 | |
| 17 | 6 | |
| 18 | 16 | |
| 19 | 50 | |
| 20 | 35 |
About Mohsen Rashidi
Mohsen Rashidi is a scholar working on Cancer Research, Toxicology and Applied Microbiology and Biotechnology, having authored 96 papers that have together received 1.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (22 papers), Cancer-related molecular mechanisms research (22 papers) and Circular RNAs in diseases (18 papers). The work is most often cited by research in Cancer Research (488 citations), Molecular Biology (996 citations) and Biomaterials (174 citations). Mohsen Rashidi has collaborated with scholars based in Iran, Canada and China. Frequent co-authors include Mehrdad Hashemi, Afshin Taheriazam, Maliheh Entezari, Shokooh Salimimoghadam, Kiavash Hushmandi, Marjan Ghorbani, Sepideh Mirzaei, Matin Chehelgerdi, Mohammad Chehelgerdi and Noushin Nabavi. Their work appears in journals such as SHILAP Revista de lepidopterología, Cellular and Molecular Life Sciences and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.